TriangleHEALTH PROFESSIONAL · SOURCE READING
EBRT
Source: Gallbladder Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 12, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
The use of EBRT with or without chemotherapy as a primary treatment has been reported to produce short-term disease control in small groups of patients. Similar benefits have been reported for radiation therapy, with or without chemotherapy, administered after resection.[9,10]
There are no phase III studies to support the use of adjuvant radiation therapy, even for patients with high-risk localized disease.
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice